MIDS MEDICAL LIMITED

Dissolved Daresbury

Research and experimental development on biotechnology

1 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
M

MIDS MEDICAL LIMITED

Research and experimental development on biotechnology

Founded 13 Jun 2016 Dissolved Daresbury, United Kingdom 1 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 29 Sept 2025 Next due 30 Sept 2025 8 months overdue
Confirmation Submitted 18 Jul 2025 Next due 2 Jun 2026 10 days remaining
Net assets £-5K £11K 2023 year on year
Total assets £21K £11K 2023 year on year
Total Liabilities £26K £0 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Daresbury Sci-Tech The Innovation Centre Keckwick Lane Daresbury Cheshire WA4 4FS United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for MIDS MEDICAL LIMITED (10229764), a dissolved life sciences and medical technology company based in Daresbury, United Kingdom. Incorporated 13 Jun 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type total-exemption-full
Next accounts 30 Dec 2024
Due by 30 Sept 2025 8 months overdue

Net Assets, Total Assets & Total Liabilities (2016–2023)

Cash in Bank

£6.85k

Decreased by £1.57k (-19%)

Net Assets

-£5.43k

Decreased by £11.32k (-192%)

Total Liabilities

£26.26k

Turnover

N/A

Employees

1

Debt Ratio

126%

Increased by 44 (+54%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 88 Shares £262k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Mar 20192£52k£26k
2 Jan 20196£117k£20k
1 Jul 201680£93k£1k

Officers

Officers

2 active 1 resigned
Status
Barr, Thomas RobertDirectorBritishEngland6613 Jun 2016Active
Djennati, Nasr-eddine, DrDirectorBritishEngland6713 Jun 2016Active

Shareholders

Shareholders (3)

Bio-amd Uk Holdings Limited
57.7%
Zenosense, Inc.
38.5%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Zenosense Inc

United States Of America

Active
Notified 1 Jul 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Notified 13 Jun 2016
Nature of Control
  • Ownership Of Shares 50 To 75 Percent

Group Structure

Group Structure

MIDS MEDICAL LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Mar 2026GazetteGazette Dissolved Voluntary
29 Sept 2025AccountsAnnual accounts made up to 30 Dec 2024
18 Sept 2025Persons With Significant ControlCessation of Zenosense Inc as a person with significant control on 18 Sept 2025
18 Sept 2025Persons With Significant ControlNotification of a person with significant control statement
4 Sept 2025Persons With Significant ControlCessation of Bio-Amd Uk Holdings Limited as a person with significant control on 18 Mar 2025
24 Mar 2026 Gazette

Gazette Dissolved Voluntary

29 Sept 2025 Accounts

Annual accounts made up to 30 Dec 2024

18 Sept 2025 Persons With Significant Control

Cessation of Zenosense Inc as a person with significant control on 18 Sept 2025

18 Sept 2025 Persons With Significant Control

Notification of a person with significant control statement

4 Sept 2025 Persons With Significant Control

Cessation of Bio-Amd Uk Holdings Limited as a person with significant control on 18 Mar 2025

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 months ago on 24 Mar 2026

Annual accounts made up to 30 Dec 2024

7 months ago on 29 Sept 2025

Cessation of Zenosense Inc as a person with significant control on 18 Sept 2025

8 months ago on 18 Sept 2025

Notification of a person with significant control statement

8 months ago on 18 Sept 2025

Cessation of Bio-Amd Uk Holdings Limited as a person with significant control on 18 Mar 2025

8 months ago on 4 Sept 2025